Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019

No Comments found.

By using this site, you agree to the Terms of Service and Privacy Policy. Idealogs® is a registered trademark of the Idealogical Foundation, Inc., a non-profit organization.
About
|
Contact
|
Docs
|
Developers
|
Donate
Idealogs Extension Icon